February 4, 2020
Oncolys BioPharma President Yasuo Urata Japan's Oncolys BioPharma will place importance on the US PII results of its oncolytic virus drug telomelysin for gastric and head and neck cancers to encourage its partner Chugai Pharmaceutical to join the agent’s development...read more